Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia

被引:0
|
作者
Medeiros, Bruno C. [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
1ST RELAPSE;
D O I
10.1159/000355134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:200 / 201
页数:2
相关论文
共 50 条
  • [31] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    Samantha O‘Hagan Henderson
    Jochen J. Frietsch
    Inken Hilgendorf
    Andreas Hochhaus
    Claus-Henning Köhne
    Jochen Casper
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2599 - 2609
  • [32] Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin
    McHayleh, Wassim
    Sehgal, Rajesh
    Redner, Robert L.
    Raptis, Anastasios
    Agha, Mounzer
    Natale, James
    Luong, The Minh
    Schlesselman, James J.
    Foon, Kennteh A.
    Boyiadzis, Michael
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1848 - 1853
  • [33] Acute myeloid leukemia in the elderly: What about etoposide when anthracyclines are contraindicated ?
    de Latour, RP
    Chaoui, D
    Legrand, O
    Rio, B
    Marie, JP
    BLOOD, 2002, 100 (11) : 259B - 259B
  • [34] Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience
    Kohrt, Holbrook E.
    Patel, Samit
    Ho, Michelle
    Owen, Terri
    Pollyea, Daniel A.
    Majeti, Ravindra
    Gotlib, Jason
    Coutre, Steve
    Liedtke, Michaela
    Berube, Caroline
    Alizadeh, Ash A.
    Medeiros, Bruno C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (11) : 877 - 881
  • [35] MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia
    Marconi, Giovanni
    Talami, Annalisa
    Abbenante, Maria Chiara
    Sartor, Chiara
    Parisi, Sarah
    Nanni, Jacopo
    Bertamini, Luca
    Ragaini, Simone
    Olivi, Matteo
    de Polo, Stefano
    Cristiano, Gianluca
    Fontana, Maria Chiara
    Bochicchio, Maria Teresa
    Ottaviani, Emanuela
    Arpinati, Mario
    Sessa, Mariarosaria
    Baldazzi, Carmen
    Caso, Lucia
    Testoni, Nicoletta
    Baccarani, Michele
    Bonifazi, Francesca
    Martinelli, Giovanni
    Paolini, Stefania
    Cavo, Michele
    Papayannidis, Cristina
    Curti, Antonio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (01) : 47 - 55
  • [36] Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia
    Styczynski, Jan
    Toporski, Jacek
    Wysocki, Mariusz
    Debski, Robert
    Chybicka, Alicja
    Boruczkowski, Dariusz
    Wachowiak, Jacek
    Wojcik, Beata
    Kowalczyk, Jerzy
    Gil, Lidia
    Balwierz, Walentyna
    Matysiak, Michal
    Krawczuk-Rybak, Maryna
    Balcerska, Anna
    Sonta-Jakimczyk, Danuta
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1547 - 1551
  • [37] Cytarabine Dose for Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2168 - 2169
  • [38] Cytarabine and skin reactions in acute myeloid leukemia
    Grille, Sofia
    Guadagna, Regina
    Boada, Matilde
    Irigoin, Victoria
    Stevenazzi, Mariana
    Guillermo, Cecilia
    Diaz, Lilian
    MEDICINA-BUENOS AIRES, 2013, 73 (06) : 535 - 538
  • [39] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [40] Use of fludarabine in the treatment of acute myeloid leukemia
    Jackson, GH
    HEMATOLOGY JOURNAL, 2004, 5 : S62 - S67